Triage Method for Out-of-Hospital Poisoned Patients by Kwon, Woon Yong et al.
INTRODUCTION
Poisonings are the second most common cause of deaths
related to injuries in Korea. It is associated with more than
four thousand unexpected deaths and occupies 0.5 to 1.9%
of emergency department (ED) visits per year (1).
According to the 2000 annual report of the American asso-
ciation of poison control centers (AAPCC) toxic exposure sur-
veillance system (TESS), a total of 2,168,248 poisoned patients
visited 63 poison control centers for one year in US. Among
these patients, no toxicity was found in 818,323 (37.7%)
patients, and only minimal toxicity in 1,082,047 (49.9%)
(2, 3). The previous studies consistently reported that unnec-
essary ED visits due to poisonings may be reduced with the
use of proper triage methods (4, 5). This reduction was accom-
plished, especially in children, over 50% (4). Those studies
also suggested that a triage method should be developed for
the efficient control of the out-of-hospital poisoned patients
(5, 6). With the requirements aforementioned, ‘the guideline
for the out-of-hospital management of human exposures to
minimally toxic substances’ was approved in 2003 by AAPCC
consensus panel (the AAPCC guideline) (3).
In Korea, there have been 12 local emergency medical infor-
mation centers organized by the Ministry of Health and Wel-
fare since 2000 (7). Each center collects real-time data from
hospitals to obtain information on the availability of medical
facilities through an automatic report system, and provides
emergency medical advices to the lay persons who are in trou-
ble. The Seoul Emergency Medical Information Center (SE-
MIC) is responsible for Seoul, which is the largest city in Korea,
and 10,276,968 people live in (8). Four physicians with 12
emergency medical technicians (EMTs) are working at the
SEMIC as emergency medical advisers. They provide guid-
ance of emergency care and information relating hospital data,
which were required to the out-of-hospital patients, to callers.
The SEMIC collects data from 61 medical institutes in Seoul
and receives more than 70,000 calls from lay persons per year
(7). The calls relating out-of-hospital poisonings occupy 0.5%
of the total calls. Until now, however, there has been neither
triage method nor toxic exposure surveillance system for the
out-of-hospital poisoned patients.
The aim of this study was to develop and evaluate a triage
method to prevent the unnecessary ED visits of out-of-hos-
pital poisoned patients.
MATERIALS AND METHODS
Study design
This study was a prospective, observational study using a
triage protocol with reference to the AAPCC guideline for
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Triage Method for Out-of-Hospital Poisoned Patients
The aim of this study was to develop and evaluate a triage method to prevent unne-
cessary emergency department visits of out-of-hospital poisoned patients. From
October 2003 to September 2004, the calls that lay persons gave to the Seoul Emer-
gency Medical Information Center to seek advices on the out-of-hospital poisoned
patients were enrolled. We designed a triage protocol that consisted of five factors
and applied it to the patients. According to the medical outcomes, we classified the
patients into two groups, the toxicity-positive and the toxicity-negative. We arranged
the factors on the basis of the priority that was determined in order of the odds ratio
of each factor for the toxicity-positive and made a flow chart as a triage method. Then
we calculated a sensitivity, specificity, positive predictive value and negative pre-
dictive value of the method. We regarded the specificity as the ability of the method
and the sensitivity as the safety. A total of 220 patients were enrolled in this study.
The method showed a sensitivity, specificity, positive predictive value, and nega-
tive predictive value of 99.2%, 53.4%, 76.2%, and 97.9%, respectively. Our triage
method prevented 53.4% of the unnecessary emergency department visits of out-
of-hospital acutely poisoned patients, safely.
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out-of-hospital poisoned patients (3). The Seoul National
University Collage of Medicine/Seoul National University
Hospital Institutional Review Board reviewed our investi-
gation and article.
Study setting & population
From October 2003 to September 2004, telephone calls
that lay persons gave to the SEMIC to seek advices of us on
poisoned patients were enrolled. Exclusion criteria were the
calls that were not able to offer adequate histories due to hang-
up or inappropriate communication or the calls that were
not able to offer medical outcome during follow-up proce-
dures (3). When the responders of SEMIC decided that the
patient had a critical situation requiring prompt resuscita-
tion, they ordered the caller to start resuscitation without
delay and excluded the case from this study.
Study protocol
We designed a triage protocol consisted of five factors and
applied it to the patients who were consecutively enrolled
during the study period (Fig. 1). We used the list, ‘the exam-
ples of minimally toxic substances approved by the AAPCC
panel’, to distinguish minimally toxic substances from other
toxic substances (3). We also used four factors to decide pa-
tient’s disposition on the basis of the AAPCC panel’s sugges-
tion, which were patient’s intent, symptoms or signs, social
environment, and individual patient circumstances (3).
From the histories, we found out the identity of the sub-
stances involved in the exposures, estimated the maximum
amount of the substances, and secured the symptoms or signs
that the patients complained of (3). To identify the ingredi-
ents of substances, we investigated web or references recom-
mended in the guideline (3). If we failed to identify the ing-
redients of substances, we regarded the substances as toxic.
We regarded only the substances that were implicated in the
list as minimally toxic (3).
According to the protocol, we divided the patients into
the two groups, the high-risk group and the low-risk group
(Fig. 1). Then, we recommended an immediate ED visit to
the patients in the high-risk group and recommended a close-
observation in pre-hospital state to the patients in the low-
risk group. To prevent adverse effects, we also recommend-
ed they should visit ED as soon as possible, if the patients in
the low-risk group were in trouble during a period of obser-
vation (9).
Measurements
Nine EMTs of SEMIC were educated on the protocol for
4 hr and obtained the histories of patients from callers accord-
ing to the data table of TESS reports (10-13). Table 1 shows
medical outcomes. To acquire the medical outcomes of the
patients, follow-up procedures were performed. We made a
telephone call to the caller within 3 months after the initial
call. If we had failed to connect the caller or acquire the medi-
cal outcome of the patient from the caller till 3rd trial, we
regarded the case as the follow-up failure and excluded it from
this study. According to the medical outcomes, we assigned
the patients to the two groups, the toxicity-positive and the
toxicity-negative.
Data analysis
To determine of the priority of the factors in the triage pro-
tocol, we calculated the odds ratio (OR) of each factor for the
toxicity-positive using chi-square test and Fisher’s exact test
of the SPSS 11.0 for Windows. On the basis of the priority,
we developed a flow chart as a triage method. We also calcu-
Factors Yes No
1. Minimally toxic substances?*
2. Un-intentional exposures?                                                                                                          
3. Without symptoms or signs?
�
4. Without pre-existing medical problems, current medication, pregnancy, or breast-feeding?
�
5. Safe environment & observation possible?
�
If all of the answers are ‘YES’ If any one of the answers are ‘NO’
The low risk group The high risk group
Fig. 1. Triage Protocol. *Examples of minimally toxic substances approved by the AAPCC panel (3), 
� Clinical effects captured by TESS data
(10), 
� Individual patient circumstances (3), 
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lated the sensitivity, specificity, positive predictive value and
negative predictive value of the method. We regarded the
value of specificity as the ability to reduce of the unnecessary
ED visits in the toxicity-negative group, and the value of
sensitivity as the safety of the method to recommend no ED
visit in the low risk group.
RESULTS
From October 2003 to September 2004, a total of 292 calls
to seek the medical information relating poisoned patients
were given to the SEMIC by lay persons. Twenty six calls
(8.9%) were not able to offer adequate histories. Of these
calls, hang up were nineteen calls (73.1%) and inappropri-
ate communication were seven calls (26.9%). One call (0.3%)
required prompt resuscitation and we failed to obtain ade-
quate histories from the caller. Forty five calls (15.4%) were
regarded as follow-up failure by us. During the follow-up
procedures, we failed to contact the caller in 32 calls (71.1%),
and we failed to obtain medical outcome from the caller in
13 calls (28.9%). Finally, two hundred twenty calls (75.4%)
were included in this study and each call was attributable to
a separate case.
Table 2 and 3 display the obtained histories from the callers.
Table 4 shows the ORs of the five factors for the toxicity-posi-
tive in the triage protocol. Fig. 2 shows the flow chart as a
triage method according to the priority of ORs of the five
*Toxic effects captured by TESS data (10).
Toxicity-positive Patients with moderate, major effect or death*,
or hospital discharge with therapeutic interven-
tions, or admission
Toxicity-negative Patients with no or minor effect*, and pre-hos-
pital observation only, or hospital discharge 
without therapeutic interventions
Table 1. Medical outcome categories
*Percentages are based on the total number of human exposures rather
than the total number of symptoms or signs.
Gender
Male 26 (11.8) 77 (35.0) 103 (46.8)
Female 22 (10.0) 95 (43.2) 117 (53.2)
Age
Children (<20 yr) 43 (19.5) 70 (31.8) 113 (51.4)
Adult (≥20 yr) 5 (2.3) 102 (46.3) 107 (48.6)
Caller
Family 44 (20.0) 147 (66.8) 191 (86.8)
Others 4 (1.8) 25 (11.4) 29 (13.2)
Site
Residency 48 (21.8) 154 (70.0) 202 (91.8)
Others 0 (0.0) 18 (8.2) 18 (8.2)
Pre-existing medical conditions
None 48 (21.8) 128 (58.2) 176 (80.0)
Chronic disease 0 (0.0) 10 (4.5) 10 (4.5)
Psychiatric disease 0 (0.0) 5 (2.3) 5 (2.3)
Pregnancy 0 (0.0) 0 (0.0) 0 (0.0)
Breast-feeding 0 (0.0) 1 (0.5) 1 (0.5)
Current medication 0 (0.0) 23 (10.5) 23 (10.5)
Others 0 (0.0) 3 (1.4) 3 (1.4)
Unknown 0 (0.0) 25 (11.4) 25 (11.4)
Symptoms or signs*
None 48 (21.8) 91 (41.4) 139 (63.2)
Neurological 0 (0.0) 38 (17.3) 38 (17.3)
Gastrointestinal 0 (0.0) 22 (10.0) 22 (10.0)
Dermal/ocular 0 (0.0) 5 (2.3) 5 (2.3)
Respiratory 0 (0.0) 2 (0.9) 2 (0.9)
Cardiovascular 0 (0.0) 1 (0.5) 1 (0.5)
Renal/genitourinary 0 (0.0) 1 (0.5) 1 (0.5)
Miscellaneous 0 (0.0) 12 (5.5) 12 (5.5)
Safe environment & observation possibility
Yes 48 (21.8) 164 (74.6) 212 (96.4)
No 0 (0.0) 8 (3.6) 8 (3.6)
Sum 48 (21.8) 172 (78.2) 220 (100.0)
Table 2. Host and environmental findings                  Number (%)
Low risk
(N=48)
High risk
(N=172)
Total
(N=220)
*Percentages are based on the total number of human exposures rather
than the total number of substances. 
� Herbs mean Korean traditional
herbal remedies. 
� Other categories contained electrolytes & minerals,
foreign body, arts/crafts/office supplies, GI preparations, antimicrobials,
cardiovascular drugs, fume/gas/vapor, antidepressant, anticonvulsant,
and herbicides.
Duration of exposures
Acute 48 (21.8) 172 (78.2) 220 (100.0)
Subacute or chronic 0 (0.0) 0 (0.0) 0 (0.0)
Substances involved in exposures*
Sedatives/hypnotics/ 0 (0.0) 48 (21.8) 48 (21.8)
antipsychotic
Cleaning substances 10 (4.5) 18 (8.2) 28 (12.7)
Analgesics 0 (0.0) 24 (10.9) 24 (10.9)
Pesticides 0 (0.0) 18 (8.2) 18 (8.2)
Silica gel 13 (5.9) 1 (0.5) 14 (6.4)
Cough & cold preparations 0 (0.0) 12 (5.5) 12 (5.5)
Cosmetics & care product 8 (3.6) 3 (1.4) 11 (5.0)
Hydrocarbon 7 (3.2) 4 (1.8) 11 (5.0)
Chemicals 1 (0.5) 6 (2.7) 7 (3.2)
Plant/food product 1 (0.5) 6 (2.7) 7 (3.2)
Alcohols 0 (0.0) 6 (2.7) 6 (2.7)
Topical 4 (1.8) 1 (0.5) 5 (2.3)
Herbs
� 0 (0.0) 5 (2.3) 5 (2.3)
Other categories
� 4 (1.8) 20 (9.0) 24 (10.8)
Reason
Unintentional 48 (21.8) 85 (38.7) 133 (60.5)
Intentional or unknown 0 (0.0) 87 (39.5) 87 (39.5)
Route
Ingestion 47 (21.3) 166 (75.5) 213 (96.8)
Inhalation 0 (0.0) 3 (1.4) 3 (1.4)
Dermal or ocular 1 (0.5) 3 (1.4) 4 (1.8)
Sum 48 (21.8) 172 (78.2) 220 (100.0)
Table 3. Toxic substances and exposures findings   Number (%)
Low risk
(N=48)
High risk
(N=172)
Total
(N=220)Clinical Application of AAPCC Guideline 339
factors. The value of sensitivity and specificity of the triage
method was 99.2% and 53.4%, respectively (Table 5). False
negative case was shown in only one patient (1/48). 
The patient was a 32-yr-old male and exposed to small
amount of Madecassol ointment by ingestion. After five min-
utes of the exposure, he made a call to the SEMIC without
any symptoms or signs. The EMT of SEMIC classified him
as the lower risk group and recommended to stay at home
with observation. About 30 min later, he felt abdominal pain
and visited an ED. With an infusion of fluid and pain killer,
abdominal pain was subsided. He was discharged from the
hospital and did not complain of any more symptoms or signs.
Of the 172 patients in the high-risk group, 41 patients
(23.8%) were assigned to the toxicity-negative. Table 6 illus-
trates the causes of these false positives.
*Clinical effects captured by TESS data (10), 
� Examples of minimally toxic substances approved by the AAPCC panel (3).
Unintentional exposure?
No 87 86 (98.9) 1 (1.1) 162.65 21.94-1205.99 <0.001
Yes 133 46 (34.6) 87 (65.4)
Without symptoms or signs?*
No 81 78 (96.3) 3 (3.7) 40.93 12.30-136.22 <0.001
Yes 139 54 (38.8) 85 (61.2)
Minimally toxic substances?
�
No 155 121 (78.1) 34 (21.9) 17.47 8.24-37.05 <0.001
Yes 65 11 (16.9) 54 (83.1)
Without pre-existing medical problems, current medication, pregnancy, or breast-feeding?
No 43 37 (86.0) 6 (14.0) 5.32 2.14-13.25 <0.001
Yes 177 95 (53.7) 82 (46.3)
Safe environment & observation possible?
No 8 7 (87.5) 1 (12.5) 4.87 0.59-40.31 0.149
Yes 212 125 (59.0) 87 (41.0)
Table 4. Odds ratio (OR) of factors for the toxicity-positive                                                                                                            Number (%)
Factors
Toxicity positive
(N=132)
Toxicity negative
(N=88)
OR 95% CI
p value
(<0.05)
Total (N=220)
Sensitivity, specificity, positive predictive value, and negative predictive
value were calculated as 99.2%, 53.4%, 76.2%, and 97.9%, respectively.
Toxicity-positive Toxicity-negative Sum
High-risk group 131 41 172
Low-risk group 1 47 48
Sum 132 88 220
Table 5. Results of the triage method                                Number
*Other categories contained GI preparations, foreign body, plant/food
product, alcohols, and miscellaneous.
Causes False-positive patients
Intentional or unknown exposures 1 (2.4)
With symptoms or signs 2 (5.0)
Toxic substances 32 (78.0)
Pesticides 14 (34.1)
Electrolytes & minerals 3 (7.3)
Hydrocarbon 2 (4.9)
Chemicals 2 (4.9)
Other categories* 11 (26.8)
With pre-existing medical conditions 5 (12.2)
Unsafe environment & observation impossible 1 (2.4)
Sum 41 (100.0)
Table 6. Causes of false positives                               Number (%)
Enrolled cases
(N=220)
Unintentional 
exposures
(N=133)
Intentional exposures
(N=87)
Without
symptoms or signs
(N=112)
With
symptoms or signs
(N=21)
Minimally toxic
substances
(N=54)
Toxic substanses
(N=58)
Without pre-existing
medical conditions/
medication pregnant
breast-feeding
(N=49)
Safe environment &
observation possible*
(N=48)
With pre-existing 
medical conditions/
medication pregnant
breast-feeding
(N=5)
Unsafe environment &
observation impossible
(N=1)
Low-risk group
(N=48)
High-risk group
(N=172)
Fig. 2. Flow chart as triage method.
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DISCUSSION
The primary goals of the AAPCC guideline are to estab-
lish principles to aid in identifying a minimally toxic sub-
stance, to provide examples of substances that meet the prin-
ciples, and to provide an approach to adding additional sub-
stances to the list (3). It is the first standardized guideline for
the triage of the out-of-hospital poisoned patients and com-
posed of methods of data collection, a definition of minimally
toxic substances, a consensus of the guideline, a process to
determine if a substance should be added to the minimally
toxic list, and a need of follow-up procedures (3). In the gui-
deline, on the assumption that all substances are capable of
producing toxicity and nothing is completely non-toxic, the
panel defined the minimally toxic substances as those which
produce little toxicity, minor self-limited toxicity, or clinically
insignificant effect at most doses (3). After going over liter-
atures and taking into account the expert opinions of its mem-
bers, the panel selected 30 examples of minimally toxic sub-
stances and then approved 25 among them (3). In the guide-
line, the panel also suggested that the decisions regarding
patient disposition should take into account the patient’s
intent, symptoms, social environment, and individual patient
circumstances (e.g., pregnancy, pre-existing medical condi-
tions, and current medications) (3). Of these contents of the
guideline, we cited the minimally toxic list and the factors
that should be considered in decisions regarding patient dis-
position because the aim of this study was to develop and
evaluate a triage method for the out-of-hospital poisoned
patients (Fig. 1).
The sensitivity and the negative predictive value of the
triage method were 99.2% and 97.9%, respectively (Table
5). It means that the high-risk group designation predicts
almost all the toxicity positive patients. This method can be
used safely. The specificity and the positive predictive value
of the method were 53.4% and 76.2%, respectively (Table
5). It means that this triage method is able to reduce more
than a half of the unnecessary ED visits of the out-of-hospi-
tal poisoned patients. However, the specificity and the posi-
tive predictive value of the method were not so high. It might
be an inevitable result in this study. Since it is impossible to
provide direct physical examinations or immediate therapeu-
tic interventions to the poisoned patients by telephones, it
is very important to reduce false negatives (3-5, 14).
Madecassol ointment was the only one substance caused
false negative in this study. It is composed of Centella asiatica
products, neomycin, and hydrocortisone and it is categorized
into ‘corticosteroids, topical with antibiotics’ (15). Accord-
ing to ‘the examples of minimally toxic substances approved
by the AAPCC panel’, it is included in the minimally toxic
substances (3). In a few cases, however, the Madecassol oint-
ment ingestion has been reported to disturb digestive system
and cause gastrointestinal symptoms, which would be fully
recovered with appropriate therapies (15, 16).
The most common cause of the false positives was the sub-
stances regarded as toxic (Table 6). More substances should
be identified as minimally toxic for the reduction of false
positives, through the process proposed by the AAPCC panel,
involving a review of current literatures, a thorough analysis
of poison experience, and prospective validation (3).
We designed this protocol with reference to the AAPCC
guideline and collected data according to the data table of
TESS reports (2, 3, 11-13). However, there were some limi-
tations addressed in the AAPCC guideline and TESS. Firstly,
drug identification principles were not developed. Drug iden-
tification practices varied from center to center throughout
the United States and amount estimation depended on the
histories obtained from callers (5, 17). Secondly, the optimal
sources for the outcome were not established (3, 5). The TESS
data recognized several different toxic effects as the medical
outcome categories (10). However, the data had inherent limi-
tations and using them alone was problematic and not satis-
factory (3). Additional data sources were required for the med-
ical outcome to provide an accurate perspective on the feasi-
bility of the triage method (3). For the additional data sources,
we obtained more information during follow-up procedures
on ED visits, therapeutic interventions, and hospital admis-
sions.
In addition to the above limitations, there were other limi-
tations in this study. Firstly, the distribution of the study pop-
ulation inclined toward the patients acutely exposed in safe
environments. Most of the calls were given to us by the family
members at home (Table 2). In other words, most of the pa-
tients were located in safe environments where their family
members could take care of them. In addition, chronically
exposed patients were not included (Table 2). Since most of
the chronically poisoned patients had no idea of poisonings,
they called us not to obtain information on poisonings but
to obtain information on other problems, such as chronic
headache, chronic diarrhea, depression, or others. Initially,
we could not recognize them as poisoned patients and failed
to apply the protocol to them. Secondly, all exposures occurred
in the restricted region, Seoul. Compared with 2003 annual
report of the AAPCC TESS, most of the demographic find-
ings of this study were similar to those of the report, but the
substances commonly involved in exposures of the two were
different (Table 3) (13). Many studies reported that the nature
of exposure in one region can differ from that of another, and
the difference is determined by the regional environmental
factors (17, 18). However, the EMTs of SEMIC provided
advices to the persons lived in Seoul, and they could not ob-
tain information on toxic exposures occurred in other regions
than Seoul in this study. Finally, we failed to identify the ingre-
dient of herbs, Korean traditional herbal remedies. Most of
the herbs are composed of several unknown plants and we
were not able to find any reference in the ingredient of the
herbs. In this study, nine (4.1%) patients took the herbs and
five (2.3%) were intoxicated. The composition and the toxi-Clinical Application of AAPCC Guideline 341
cities of herbs should be identified through the process pro-
posed by the AAPCC panel (3). Despite these limitations,
this study was the first trial to develop and evaluate a triage
method to prevent unnecessary ED visits of out-of-hospital
poisoned patients, with reference to the AAPCC guideline.
Our triage method with reference to ‘the guideline for the
out-of-hospital management of human exposures to mini-
mally toxic substances’ approved by the AAPCC consensus
panel prevented more than half of unnecessary ED visits of
out-of-hospital acutely poisoned patients, safely.
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